DermTech, Inc. (DMTK)
NASDAQ: DMTK · IEX Real-Time Price · USD
0.702
-0.007 (-0.99%)
At close: Mar 28, 2024, 4:00 PM
0.710
+0.008 (1.13%)
After-hours: Mar 28, 2024, 5:41 PM EDT

DermTech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182016
Cash & Equivalents
40.2181.25179.9124.2515.374.750.03
Short-Term Investments
19.1248.4148.4539.53000
Cash & Cash Equivalents
59.33129.66228.3663.7815.374.750.03
Cash Growth
-54.24%-43.22%258.05%314.84%223.46%18912.00%-
Receivables
2.584.173.851.480.680.580
Inventory
11.760.480.10.040.040
Other Current Assets
-1.170.450.141.521.060.030
Total Current Assets
61.75136.04232.8266.8817.155.40.03
Property, Plant & Equipment
56.7162.3812.292.730.980.220
Other Long-Term Assets
3.473.663.190.170.080.050.17
Total Long-Term Assets
60.1866.0415.492.91.060.270.17
Total Assets
121.93202.08248.3169.7818.215.660.19
Accounts Payable
1.482.422.881.571.610.290
Deferred Revenue
0.20.111.381.541.391.550
Current Debt
3.091.751.570.1105.020.17
Other Current Liabilities
8.6811.366.352.22.723.650
Total Current Liabilities
13.4515.6412.185.435.7210.50.17
Long-Term Debt
51.3154.086.280.2300.520
Other Long-Term Liabilities
00.010.152.29000
Total Long-Term Liabilities
51.3154.096.432.5200.520
Total Liabilities
64.7669.7218.617.945.7211.020.17
Total Debt
54.3955.837.860.3405.540.17
Debt Growth
-2.57%610.50%2245.67%--3193.92%-
Retained Earnings
-423.94-323.05-206.36-128.03-91.11-71.38-0
Comprehensive Income
0.18-0.77-0.12-0000
Shareholders' Equity
57.18132.35229.761.8412.49-5.360.02
Net Cash / Debt
4.9473.83220.563.4415.37-0.78-0.14
Net Cash / Debt Growth
-93.31%-66.52%247.56%312.66%---
Net Cash Per Share
0.152.467.633.742.19-0.18-0.08
Working Capital
48.31120.4220.6461.4611.43-5.1-0.15
Book Value Per Share
1.754.417.953.641.78-1.210.01
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).